liposome doxorubicin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for liposome doxorubicin, covering 2022-09-30 to 2022-09-30. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor [Phase 3]